Global Macular Degeneration Treatment Market 2022 – Market Opportunities And Strategies
The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.
Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!
The macular degeneration treatment market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 7%, as per The Business Research Company’s market report!
Read More On The Macular Degeneration Treatment Market Report 2022 – https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report
The Macular Degeneration Treatment Market Size In 2022 And Forecast
The global macular degeneration treatment market is expected to grow from $7.55 billion in 2021 to $8.08 billion in 2022 at a compound annual growth rate (CAGR) of 7.04%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The macular degeneration treatment market is expected to reach $10.65 billion in 2026 at a CAGR of 7.15%.
The macular degeneration treatment market consists of sales of macular degeneration treatments by entities (organizations, sole traders, and partnerships) that are used to treat macular degeneration eye disease.
Request for A Sample Of The Global Macular Degeneration Treatment Market Report:
The Increase In Burden Of Retinal Disorders Is Driving The Growth Of The Macular Degeneration Treatment Market
According to a study done in Tanzania in 2020 about the prevalence of retinal diseases and associated risk factors, out of 1,007 people, the prevalence of vitreoretinal disorders was 22.8% (230/1,007). The study was conducted by OSLI Retina, which focuses solely on retinal diseases, surgery, and pharmacotherapy. The leading retinal diseases were age-related hypertensive macular scars (2.7%), retinopathy (4.5%), and degeneration (7.0%). According to the American Academy of Ophthalmology, in 2050, an estimated 7.32 million people in the United States will have primary open-angle glaucoma, with the highest numbers among populations aged 70 to 79 years (32%), women (50%), and Hispanics (50%). The largest demographic group is Hispanic men. Therefore, the increasing burden of retinal disorders is driving the growth of the macular degeneration treatment market.
Competitive Landscape And The Regional Analysis Of The Macular Degeneration Treatment Market
Major players in the macular degeneration treatment market are Novartis AG, Bausch Health Companies Inc, Regenxbio Inc, F Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, GlaxoSmithKline plc, Bayer AG, Neurotech Pharmaceuticals Inc, Ophthotech Corporation, StemCells Inc, Pfizer Inc, Santen Pharmaceuticals, Alimera Sciences Inc, Aerie Pharmaceutical Inc, Panoptica, Allergan Inc, Valeant Pharmaceuticals, and Rxi Pharmaceuticals Inc.
Additionally, as per TBRC’s research – North America was the largest region in the macular degeneration treatment market in 2021 holding the largest market share and Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The Macular Degeneration Treatment Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the macular degeneration treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the macular degeneration treatment market.
Development Of Advanced Therapies – A Key Trend In The Macular Degeneration Treatment Market
Advanced therapy, including gene therapy, for the treatment of disease has seen development in recent years, particularly in the world of inherited retinal disease.
Macular Degeneration Treatment Market Segmentation By The Business Research Company
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
3) By Route of Administration: Oral, Injectable, Others
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration
Here Are Some Reports Related To The Macular Degeneration Treatment Market –
Get In Touch With Us – Call us at:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Found this article helpful? Share it on: